Table 3 of
Micheal, Mol Vis 2014; 20:1471-1479. Table 3 of
Micheal, Mol Vis 2014; 20:1471-1479.
Table 3. Allele frequencies in POAG, PACG, PEXG patients and controls.
| Alleles | POAG n=536 (%) | Controls n=466 (%) | p (χ2) | OR (95% CI) | PACG n=250 (%) | p (χ2) | OR (95% CI) | PEXG n=240 (%) | p (χ2) | OR (95% CI) |
|---|---|---|---|---|---|---|---|---|---|---|
| CDKN2B-AS1 rs4977756 | ||||||||||
| A | 395 (73.7) | 351 (75.3) | 0.55 (0.35) | 0.92 (0.68-1.23) | 191 (76.4) | 0.74 (0.10) | 0.94 (0.65-1.37) | 173 (72.1) | 0.35 (0.87) | 1.18 (0.82-1.71) |
| G | 141 (26.3) | 115 (24.7) | 59 (23.6) | 67 (27.9) | ||||||
| CDKN2B rs1063192 | ||||||||||
| T | 384 (71.6) | 343 (73.6) | 0.48 (0.48) | 0.91 (0.68-1.21) | 190 (76.0) | 0.48 (0.49) | 0.88 (0.61-1.28) | 172 (71.7) | 0.58 (0.30) | 1.10 (0.77-1.58) |
| C | 152 (28.4) | 123 (26.4) | 60 (24.0) | 68 (28.3) | ||||||
| ATOH7 rs1900004 | ||||||||||
| C | 349 (65.1) | 318 (68.2) | 0.29 (1.10) | 0.87 (0.66-1.14) | 189 (75.6) | 0.03 (4.26) | 0.69 (0.48-1.00) | 153 (63.75) | 0.23 (1.44) | 1.22 (0.87-1.72) |
| T | 187 (34.9) | 148 (31.8) | 61 (24.4) | 87 (35.25) | ||||||
| CAV1 rs4236601 | ||||||||||
| G | 395 (73.7) | 376 (80.7) | 0.008 (6.87) | 1.49 (1.09-2.04) | 193 (77.2) | 0.27 (1.21) | 0.81 (0.55-1.20) | 187 (77.9) | 0.38 (0.75) | 1.18 (0.79-1.77) |
| A | 141 (26.3) | 90 (19.3) | 57 (22.8) | 53 (22.1) | ||||||
| TMCO1 rs4656461 | ||||||||||
| A | 485 (90.5) | 393 (84.3) | 0.003 (8.70) | 0.57 (0.38-0.89) | 228 (91.2) | 0.009 (6.66) | 0.52 (0.30-0.88) | 218 (90.8) | 0.01 (5.74) | 0.54 (0.32-0.92) |
| G | 51 (9.5) | 73 (15.7) | 22 (8.8) | 22 (9.2) | ||||||
| SIX1 rs10483727 | ||||||||||
| C | 258 (48.1) | 204 (43.8) | 0.16 (1.90) | 0.84 (0.65-1.09) | 108 (40.0) | 0.88 (0.02) | 0.98 (0.71-1.35) | 103 (42.9) | 0.82 (0.05) | 1.04 (0.75-1.44) |
| T | 278 (51.9) | 262 (56.2) | 142 (60.0) | 137 (57.1) | ||||||